SABS
SAB Biotherapeutics Inc.
$3.71
-$0.05(-1.33%)
44
Overall
60
Value
40
Tech
34
Quality
Market Cap
$33.32M
Volume
154.36K
52W Range
$1.05 - $6.60
Target Price
$9.50
EPS Estimates Overview
| Current Quarter | $-0.16 | Next Quarter | $-0.16 |
| Current Year | $-0.72 | Next Year | $-0.35 |
| QoQ Growth | +0.0% | YoY Growth | +51.4% |
| 3Y EPS CAGR | +16.4% | Target Price | $9.50 |
| Consensus | Buy | Upside | +156.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SABS | $3.71 | -1.3% | 154.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get SAB Biotherapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW